| Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone-and topotecan-resistant cell lines GL Scheffer, M Maliepaard, ACLM Pijnenborg, MA van Gastelen, ... Cancer Research 60 (10), 2589-2593, 2000 | 248 | 2000 |
| Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age DM van der Kolk, GH de Bock, BK Leegte, M Schaapveld, MJE Mourits, ... Breast cancer research and treatment 124, 643-651, 2010 | 227 | 2010 |
| Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia DM van der Kolk, E Vellenga, GL Scheffer, M Müller, SE Bates, ... Blood, The Journal of the American Society of Hematology 99 (10), 3763-3770, 2002 | 174 | 2002 |
| P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia DM van der Kolk, EGE de Vries, WLJ van Putten, LF Verdonck, ... Clinical cancer research 6 (8), 3205-3214, 2000 | 141 | 2000 |
| Establishing long-term cultures with self-renewing acute myeloid leukemia stem/progenitor cells D van Gosliga, H Schepers, A Rizo, D van der Kolk, E Vellenga, ... Experimental hematology 35 (10), 1538-1549, 2007 | 116 | 2007 |
| Activity and expression of the multidrug resistance proteins MRP1 and MRP2 in acute myeloid leukemia cells, tumor cell lines, and normal hematopoietic CD34+ peripheral blood cells. DM van der Kolk, EG De Vries, JA Koning, E van den Berg, M Müller, ... Clinical cancer research: an official journal of the American Association …, 1998 | 109 | 1998 |
| The role of drug efflux pumps in acute myeloid leukemia DM van der Kolk, EGE de Vries, M Müller, E Vellenga Leukemia & lymphoma 43 (4), 685-701, 2002 | 107 | 2002 |
| Activity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in de novo and relapsed acute myeloid leukemia DM Van der Kolk, EGE De Vries, L Noordhoek, E Van Den Berg, ... Leukemia 15 (10), 1544-1553, 2001 | 91 | 2001 |
| Mitoxantrone resistance in a small cell lung cancer cell line is associated with ABCA2 upregulation R Boonstra, H Timmer-Bosscha, J van Echten-Arends, DM van der Kolk, ... British journal of cancer 90 (12), 2411-2417, 2004 | 83 | 2004 |
| ATP binding cassette transporter gene expression in rat liver progenitor cells JE Ros, TAD Roskams, M Geuken, R Havinga, PL Splinter, BE Petersen, ... Gut 52 (7), 1060-1067, 2003 | 80 | 2003 |
| The role of breast cancer resistance protein in acute lymphoblastic leukemia SLA Plasschaert, DM van der Kolk, ESJM de Bont, WA Kamps, K Morisaki, ... Clinical cancer research 9 (14), 5171-5177, 2003 | 79 | 2003 |
| Feasibility of couple-based expanded carrier screening offered by general practitioners J Schuurmans, E Birnie, LM van den Heuvel, M Plantinga, A Lucassen, ... European Journal of Human Genetics 27 (5), 691-700, 2019 | 55 | 2019 |
| High functional P-glycoprotein activity is more often present in T-cell acute lymphoblastic leukaemic cells in adults than in children SLA Plasschaert, E Vellenga, ESJM de Bont, DM van der Kolk, ... Leukemia & lymphoma 44 (1), 85-95, 2003 | 55 | 2003 |
| Cytotoxicity of rhein, the active metabolite of sennoside laxatives, is reduced by multidrug resistance-associated protein 1 BAP Van Gorkom, H Timmer-Bosscha, S De Jong, DM Van der Kolk, ... British journal of cancer 86 (9), 1494-1500, 2002 | 52 | 2002 |
| Multidrug resistance protein MRP1, glutathione, and related enzymes: their importance in acute myeloid leukemia DM van der Kolk, E Vellenga, M Müller, EGE de Vries Drug resistance in leukemia and lymphoma III, 187-198, 1999 | 52 | 1999 |
| Breast cancer resistance protein (BCRP) in acute leukaemia SLA Plasschaert, DM Van Der Kolk, ESJM De Bont, E Vellenga, ... Leukemia & lymphoma 45 (4), 649-654, 2004 | 47 | 2004 |
| Deletion of the multidrug resistance protein MRP1 gene in acute myeloid leukemia: the impact on MRP activity DM van der Kolk, E Vellenga, AY van der Veen, L Noordhoek, ... Blood, The Journal of the American Society of Hematology 95 (11), 3514-3519, 2000 | 44 | 2000 |
| Selective expression of cholesterol metabolism genes in normal CD34+ CD38− cells with a heterogeneous expression pattern in AML cells SD Peeters, DM van der Kolk, G de Haan, L Bystrykh, F Kuipers, ... Experimental hematology 34 (5), 622-630, 2006 | 39 | 2006 |
| Breast Cancer Incidence After Risk-Reducing Salpingo-Oophorectomy in BRCA1 and BRCA2 Mutation Carriers IE Fakkert, MJE Mourits, L Jansen, DM van der Kolk, K Meijer, ... Cancer Prevention Research 5 (11), 1291-1297, 2012 | 35 | 2012 |
| Proven non-carriers in BRCA families have an earlier age of onset of breast cancer JR Vos, GH de Bock, N Teixeira, DM van der Kolk, L Jansen, MJE Mourits, ... European Journal of Cancer 49 (9), 2101-2106, 2013 | 20 | 2013 |
